Chronic myeloproliferative disorders
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
- The NORD Physician Guide for Chronic myeloproliferative disorders was developed as a free service of the National Organization for Rare Disorders (NORD) and it's medical advisors. The guides provide a resource for clinicians about specific rare disorders to facilitate diagnosis and treatment of their patients with this condition.
- ClinicalTrials.gov lists trials that are studying or have studied Chronic myeloproliferative disorders. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
|Generic Name||Imatinib mesylate|
(Novartis Pharmaceuticals Corp.)
The FDA has approved this product to be used in this manner.
|Treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor)|
|More Information about this product||Drug Information Portal|